Biotech

All Articles

Merck's LAG-3 combination neglects intestines cancer cells phase 3 study

.An attempt through Merck &amp Co. to open the microsatellite secure (MSS) metastatic colon cancer c...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Allies has closed a fund of 180 million euros ($ 200 million), amount of money t...

BioAge generates $198M coming from IPO as weight problems biotech participates in Nasdaq

.BioAge Labs is actually introducing almost $200 thousand via its own Nasdaq IPO this morning, with ...

Acadia takes BMS veterinarian on board as CEO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings ...

Cassava pays $40M over purportedly deceiving Alzheimer's update

.Cassava Sciences has actually accepted to spend $40 million to resolve an investigation right into ...

Merck bags possibilities on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has actually grabbed possibilities on two Evaxion Biotech vaccine prospects, paying ...

Enanta's RSV antiviral crushes popular lots in problem research

.Enanta Pharmaceuticals has connected its own breathing syncytial infection (RSV) antiviral to notab...

Biogen cans SAGE-324 collaboration after essential agitation fail

.Biogen has actually provided the last rites to its partnership along with Sage Therapeutics on SAGE...

AbbVie Parkinson's drug coming from $8.7 B Cerevel buyout credit ratings

.On the same day that some Parkinson's illness medications are actually being actually called into q...

Arch finalizes $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund from Bain Resources Lifestyle Sciences, Arch Venture Partners is ...